Inactive Instrument
Mithra Pharmaceuticals S.A. Stock
Stocks
1TM
BE0974283153
Pharmaceuticals
OTC Markets Traded| 1 day | -2.23% |
| Manager | Title | Age | Since |
|---|---|---|---|
Graham Dixon
CTO | Chief Tech/Sci/R&D Officer | 65 | 01/04/2019 |
Stijn Vlaminck
CTO | Chief Tech/Sci/R&D Officer | - | 01/05/2021 |
| Corporate Officer/Principal | - | 01/01/2013 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 77 | 08/07/1999 | |
Valérie Gordenne
BRD | Director/Board Member | 54 | 20/05/2021 |
Christian Homsy
CHM | Chairman | 67 | 29/05/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/1/23 | Sell | Director | 8,500 | 0.0152% | ||
| 19/9/22 | Buy | Chief Executive Officer | 82,372 | 0.1562% | ||
| 17/9/22 | Buy | Chief Executive Officer | 82,372 | 0.1562% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.23% | -3.20% | - | - | 13.55M | |
| +3.19% | +11.31% | +64.28% | +155.91% | 1,263B | |
| -0.73% | +3.56% | +44.65% | +84.17% | 658B | |
| +1.41% | +3.24% | +35.25% | +108.88% | 521B | |
| +0.42% | +3.20% | +55.81% | +72.50% | 391B | |
| +2.18% | +2.93% | +73.90% | +45.59% | 369B | |
| +1.12% | +4.52% | +34.76% | +58.24% | 307B | |
| +6.96% | +8.86% | +11.95% | +36.20% | 290B | |
| +1.15% | +6.09% | +56.15% | +82.25% | 252B | |
| +3.06% | +9.38% | +42.48% | +117.32% | 212B | |
| Average | +1.65% | +5.90% | +46.58% | +84.56% | 473.55B | |
| Weighted average by Cap. | +2.01% | +6.60% | +50.51% | +100.44% |
Employees
270
Sector
Pharmaceuticals
